Ovarian Cancer Awareness Month of 2019.
SCR 63 is intended to foster improvement in ovarian cancer care and research through heightened public awareness. By publicly acknowledging September as Ovarian Cancer Awareness Month, the state hopes to encourage educational initiatives, advocacy efforts, and fundraising activities aimed at enhancing research and support for patients diagnosed with ovarian cancer. The resolution recognizes that approximately 22,530 women will be diagnosed with ovarian cancer in 2019 and that the majority of these cases are diagnosed at a late stage, making public awareness crucial for improving detection and treatment outcomes.
Senate Concurrent Resolution No. 63, introduced by Senator Skinner, aims to designate September 2019 as Ovarian Cancer Awareness Month in California. The resolution seeks to raise awareness about ovarian cancer, highlighting its severity as the deadliest form of reproductive cancer among women. The resolution underscores the importance of early detection, which significantly increases survival rates, and aims to educate the community about the subtle symptoms that are often mistaken for other ailments. By proclaiming a dedicated month to this cause, the resolution intends to promote both recognition of this illness and solidarity with those affected.
The overall sentiment around SCR 63 is positive among supporters, emphasizing the importance of awareness in combating ovarian cancer. Legislators and advocacy groups generally view the resolution as a vital step towards increasing education on the necessity of early detection and the recognition of symptoms. However, the bill is rooted in a serious issue that reflects emotional and communal aspects, as it also pays tribute to those who have battled the disease and those families affected by its impact.
While SCR 63 is largely ceremonial and does not impose new regulations or funding, it serves as a platform for discussing the broader challenges women face regarding ovarian cancer. The resolution does not encounter significant opposition, but it underscores critical issues such as healthcare access, the need for effective screening methods, and the importance of research funding, which are essential in the fight against ovarian cancer. This initiative may prompt discussions about policies and measures that ensure better healthcare outcomes for women.